Advances in Immunotherapya. New treatments aim to modulate the immune system to preserve insulin-producing cells.b. Clinical trials are exploring immune checkpoint inhibitors and antigen-specific therapies.

Beta Cell Regeneration and Replacementa. Research focuses on regenerating or replacing damaged pancreatic beta cells.b. Progress includes stem cell therapy and islet cell transplantation.

Artificial Pancreas and Technologya. Improvements in continuous glucose monitors (CGMs) and automated insulin delivery systems.b. These technologies enhance blood sugar control and quality of life.

Genetic and Biomarker Researcha. Insights into genetic markers predict disease progression and therapy response.b. Potential for personalized treatment plans based on genetic profiling.

Adjunctive Therapiesa. Emerging use of medications like SGLT2 inhibitors and GLP-1 receptor agonists.b. These therapies offer benefits and have associated risks.

Relevant Medical Specialties and Advicea. Endocrinologists and diabetes educators play a key role in managing new treatments.b. Regular monitoring and consultation are crucial to adapt to evolving therapies.